Viracta Therapeutics

Viracta Therapeutics logo
🇺🇸United States
Ownership
Public
Established
2007-01-01
Employees
40
Market Cap
$8.7M
Website
http://www.viracta.com
Introduction

Viracta Therapeutics, Inc. a clinical-stage, biomarker-directed precision oncology company focused on new medicines for the treatment of virus-associated malignancies. It develops antiviral agent valganciclovir as an oral combination therapy which is in a Phase 2 clinical trial for EBV-positive lymphomas. The company was founded on February 10, 1998 and is h...

© Copyright 2024. All Rights Reserved by MedPath